Scott R. VandenBerg

48.7k total citations · 5 hit papers
152 papers, 11.9k citations indexed

About

Scott R. VandenBerg is a scholar working on Molecular Biology, Genetics and Cancer Research. According to data from OpenAlex, Scott R. VandenBerg has authored 152 papers receiving a total of 11.9k indexed citations (citations by other indexed papers that have themselves been cited), including 65 papers in Molecular Biology, 51 papers in Genetics and 32 papers in Cancer Research. Recurrent topics in Scott R. VandenBerg's work include Glioma Diagnosis and Treatment (49 papers), Protease and Inhibitor Mechanisms (11 papers) and Neuroblastoma Research and Treatments (11 papers). Scott R. VandenBerg is often cited by papers focused on Glioma Diagnosis and Treatment (49 papers), Protease and Inhibitor Mechanisms (11 papers) and Neuroblastoma Research and Treatments (11 papers). Scott R. VandenBerg collaborates with scholars based in United States, Japan and Switzerland. Scott R. VandenBerg's co-authors include Mitchel S. Berger, Soonmee Cha, M. Beatriz S. Lopes, Gabriele Bergers, Claudia Petritsch, Radosław Rola, John R. Fike, Duncan Morhardt, Jacob Raber and Kathleen R. Lamborn and has published in prestigious journals such as Cell, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

Scott R. VandenBerg

150 papers receiving 11.7k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Role of Extent of Resection in the Long-Term Outcome of Low-Grade Hemispheric Gliomas

2008 904 citations Justin S. Smith, Kathleen R. Lamborn et al. profile →
HIF1α Induces the Recruitment of Bone Marrow-Derived Vascular Modulatory Cells to Regulate Tumor Angiogenesis and Invasion

2008 902 citations Kan Lu, Scott R. VandenBerg et al. profile →
miR-124 and miR-137 inhibit proliferation of glioblastoma multiforme cells and induce differentiation of brain tumor stem cells

2008 781 citations Mamie Yu, Scott R. VandenBerg et al. profile →
Radiation-induced impairment of hippocampal neurogenesis is associated with cognitive deficits in young mice

2004 584 citations Scott R. VandenBerg et al. profile →
Radiation-Induced Cognitive Impairments are Associated with Changes in Indicators of Hippocampal Neurogenesis

2004 581 citations Scott R. VandenBerg et al. profile →

Peers

Scott R. VandenBerg

GENET

PRM

ONCOL

Peter Canoll United States

Karl H. Plate Germany

Jeffrey N. Bruce United States

Viviane Tabar United States

Robert Bachoo United States

Samuel K. Ludwin Canada

Yasuhiro Yonekawa Switzerland

Keith L. Ligon United States

Peter Hau Germany

Peter McL. Black United States

Peter Canoll United States

Scott R. VandenBerg

6.2k ×1.3

3.2k ×0.7

GENET

2.7k ×1.0

1.6k ×0.9

PRM

1.8k ×1.1

ONCOL

Citations per year, relative to Scott R. VandenBerg Scott R. VandenBerg (= 1×) peers Peter Canoll

Countries citing papers authored by Scott R. VandenBerg

Since Specialization

Citations

This map shows the geographic impact of Scott R. VandenBerg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Scott R. VandenBerg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Scott R. VandenBerg more than expected).

Fields of papers citing papers by Scott R. VandenBerg

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Scott R. VandenBerg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Scott R. VandenBerg. The network helps show where Scott R. VandenBerg may publish in the future.

Co-authorship network of co-authors of Scott R. VandenBerg

This figure shows the co-authorship network connecting the top 25 collaborators of Scott R. VandenBerg. A scholar is included among the top collaborators of Scott R. VandenBerg based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Scott R. VandenBerg. Scott R. VandenBerg is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Mori, Hidetoshi, Pierre P. Massion, Clifford Hoyt, et al.. (2020). Characterizing the Tumor Immune Microenvironment with Tyramide-Based Multiplex Immunofluorescence. Journal of Mammary Gland Biology and Neoplasia. 25(4). 417–432. 27 indexed citations

Wykosky, Jill, Jingjing Hu, German G. Gomez, et al.. (2014). A Urokinase Receptor–Bim Signaling Axis Emerges during EGFR Inhibitor Resistance in Mutant EGFR Glioblastoma. Cancer Research. 75(2). 394–404. 43 indexed citations

Farid, Nikdokht, Nathan S. White, Carrie R. McDonald, et al.. (2013). Restriction-Spectrum Imaging of Bevacizumab-Related Necrosis in a Patient with GBM. Frontiers in Oncology. 3. 258–258. 25 indexed citations

Cho, Jeonghee, Sandra Pastorino, Qing Zeng, et al.. (2011). Glioblastoma-Derived Epidermal Growth Factor Receptor Carboxyl-Terminal Deletion Mutants Are Transforming and Are Sensitive to EGFR-Directed Therapies. Cancer Research. 71(24). 7587–7596. 53 indexed citations

Khayal, Inas S., Scott R. VandenBerg, K. J. Smith, et al.. (2011). MRI apparent diffusion coefficient reflects histopathologic subtype, axonal disruption, and tumor fraction in diffuse-type grade II gliomas. Neuro-Oncology. 13(11). 1192–1201. 28 indexed citations

Schiffman, Joshua D., John Hodgson, Scott R. VandenBerg, et al.. (2010). Oncogenic BRAF Mutation with CDKN2A Inactivation Is Characteristic of a Subset of Pediatric Malignant Astrocytomas. Cancer Research. 70(2). 512–519. 185 indexed citations

Srinivasan, Radhika, Joanna J. Phillips, Scott R. VandenBerg, et al.. (2010). Ex vivo MR spectroscopic measure differentiates tumor from treatment effects in GBM. Neuro-Oncology. 12(11). 1152–1161. 35 indexed citations

McBride, Sean M., Daniel Pérez, Mei‐Yin C. Polley, et al.. (2009). Activation of PI3K/mTOR pathway occurs in most adult low-grade gliomas and predicts patient survival. Journal of Neuro-Oncology. 97(1). 33–40. 59 indexed citations

Dinca, Eduard B., Kan Lu, Jann N. Sarkaria, et al.. (2008). p53 Small-Molecule Inhibitor Enhances Temozolomide Cytotoxic Activity against Intracranial Glioblastoma Xenografts. Cancer Research. 68(24). 10034–10039. 42 indexed citations

10.

Wiencke, John K., Shichun Zheng, Tarık Tihan, et al.. (2007). Methylation of the PTEN promoter defines low-grade gliomas and secondary glioblastoma. Neuro-Oncology. 9(3). 271–279. 123 indexed citations

11.

Entin‐Meer, Michal, Xiaodong Yang, Scott R. VandenBerg, et al.. (2007). In vivo efficacy of a novel histone deacetylase inhibitor in combination with radiation for the treatment of gliomas1. Neuro-Oncology. 9(2). 82–88. 45 indexed citations

12.

Cadieux, Benoît, Tsui‐Ting Ching, Scott R. VandenBerg, & J Costello. (2006). Genome-wide Hypomethylation in Human Glioblastomas Associated with Specific Copy Number Alteration, Methylenetetrahydrofolate Reductase Allele Status, and Increased Proliferation. Cancer Research. 66(17). 8469–8476. 178 indexed citations

13.

Moots, Paul L., et al.. (1995). Prolonged Survival in Carcinomatous Meningitis Associated With Breast Cancer. Southern Medical Journal. 88(3). 357–362. 16 indexed citations

14.

Gonzalez–Fernandez, F., et al.. (1993). Differential Expression of Retinal Proteins in a Pineal Parenchymal Tumor. Journal of Neuropathology & Experimental Neurology. 52(5). 516–524. 20 indexed citations

15.

Wanebo, John E., Jacek M. Malik, Scott R. VandenBerg, et al.. (1993). Malignant peripheral nerve sheath tumors. A clinicopathologic study of 28 cases. Cancer. 71(4). 1247–1253. 241 indexed citations

16.

Gonzalez–Fernandez, F., M. Beatriz S. Lopes, José M. Garcı́a-Fernández, et al.. (1992). Expression of developmentally defined retinal phenotypes in the histogenesis of retinoblastoma.. PubMed. 141(2). 363–75. 40 indexed citations

17.

Malik, Jacek M., et al.. (1992). Remote recurrence of craniopharyngioma in the epidural space. Journal of neurosurgery. 77(5). 804–807. 48 indexed citations

18.

Phillips, Lawrence H., et al.. (1991). Electrophysiological findings in localized hypertrophic mononeuropathy. Muscle & Nerve. 14(4). 335–341. 26 indexed citations

19.

VandenBerg, Scott R. & Steven L. Gonias. (1989). Covalent complexes of albumin with serotonin, ketanserin and lysergic acid antagonize the activity of serotonin in human platelets. Life Sciences. 44(23). 1777–1785. 1 indexed citations

20.

VandenBerg, Scott R., Steven G. Britt, Gerard T. Redpath, & Steven L. Gonias. (1989). 5-Hydroxytryptamine2 (5-HT2) structure-function relationships of the nitro and amino phenylpiperazines on intact human platelets. Biochemical Pharmacology. 38(23). 4237–4244. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact